The OPAL 2 Study

The OPAL 2 Study

This study will compare the experience of using an Omnipod 5 pod pump to ‘usual care’ in people living with type 1 diabetes

The OPAL 2 Study

The OPAL 2 Study

This research study will compare the experience of using an Omnipod 5 pod pump to ‘usual care’ in people living with type 1 diabetes.

Participants will be randomly assigned to use the Omnipod 5 or their usual diabetes care method for approximately 6 months. If you are assigned to the usual care group, you will have the option to use the Omnipod 5 for approximately 3 months after completing the study.

Participation in this study will involve:

  • 26 weeks participation
  • 13 on-site and/or online clinic visits
  • Wearing a CGM +/- the Omnipod 5 Patch Pump

This trial is also recruiting participants for a regional satellite site in Wangaratta.

Become a participant!
If you:

  • are between 18-85 years old
  • have been diagnosed with type 1 diabetes for at least 1 year
  • are using an insulin pump or multiple daily injections for at least 3 months
  • have CGM sensor experience

Then you may be a good match for this study

Meet Kim Henshaw who is a participant in type 1 diabetes technology research at the DTRG. Watch Kim explain what it means to her to be a participant in this important area of research.

Get involved

Please contact the Research Group Leader to discuss your options.

*All clinical trial participants must live within traveling distance of St Vincent’s Hospital Melbourne or North Eastern Health Wangaratta, as you will be required to attend regular clinical visits during your participation

    The OPAL 2 Study

    The OPAL 2 Study

    This research study will compare the experience of using an Omnipod 5 pod pump to ‘usual care’ in people living with type 1 diabetes.

    Participants will be randomly assigned to use the Omnipod 5 or their usual diabetes care method for approximately 6 months. If you are assigned to the usual care group, you will have the option to use the Omnipod 5 for approximately 3 months after completing the study.

    Participation in this study will involve:

    • 26 weeks participation
    • 13 on-site and/or online clinic visits
    • Wearing a CGM +/- the Omnipod 5 Patch Pump

    This trial is also recruiting participants for a regional satellite site in Wangaratta.

    Become a participant!
    If you:

    • are between 18-85 years old
    • have been diagnosed with type 1 diabetes for at least 1 year
    • are using an insulin pump or multiple daily injections for at least 3 months
    • have CGM sensor experience

    Then you may be a good match for this study

    Meet Kim Henshaw who is a participant in type 1 diabetes technology research at the DTRG. Watch Kim explain what it means to her to be a participant in this important area of research.

    Get involved

    Please contact the Research Group Leader to discuss your options.

    *All clinical trial participants must live within traveling distance of St Vincent’s Hospital Melbourne or North Eastern Health Wangaratta, as you will be required to attend regular clinical visits during your participation